Penn Capital Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9,613	Closed	-$2.15M	–	164
2023 Q4	$2.15M	Sell	9,613 -621	-6%	-$143K	0.2%	98
2023 Q3	$2.35M	Sell	10,234 -63	-0.6%	-$14.5K	0.24%	99
2023 Q2	$2.27M	Buy	10,297 +16	+0.2%	+$3.54K	0.22%	101
2023 Q1	$2.36M	Sell	10,281 -1,045	-9%	-$258K	0.24%	100
2022 Q4	$3.2M	Buy	11,326 +596	+6%	+$150K	0.33%	81
2022 Q3	$2.29M	Buy	10,730 +1,838	+21%	+$411K	0.26%	99
2022 Q2	$2.1M	Buy	8,892 +932	+12%	+$189K	0.23%	105
2022 Q1	$1.43M	Sell	7,960 -416	-5%	-$79.3K	0.15%	149
2021 Q4	$1.75M	Sell	8,376 -316	-4%	-$62K	0.18%	146
2021 Q3	$1.6M	Buy	8,692 +84	+1%	+$16.5K	0.16%	152
2021 Q2	$1.54M	Buy	+8,608	New	+$1.64M	0.15%	162